Synphilin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Synphilin-1 is an α-synuclein-interacting protein encoded by the SNCAIP gene[@fujita2018]. It was originally identified through its direct binding to α-synuclein and is a major component of Lewy bodies in Parkinson's disease (PD) and related synucleinopathies.
Structure
Synphilin-1 is a 777-amino acid protein with several functional domains:
N-terminal domain: Contains the α-synuclein binding region
Central region: Coiled-coil domains for protein-protein interactions
C-terminal domain: Multiple protein interaction motifs
Key structural features:
Coiled-coil motifs mediate homodimerization
Multiple protein-protein interaction domains
Contains destruction box motifs for degradation
Normal Function
Protein Interactions
...
Synphilin-1 Protein
Introduction
Synphilin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Synphilin-1 is an α-synuclein-interacting protein encoded by the SNCAIP gene[@fujita2018]. It was originally identified through its direct binding to α-synuclein and is a major component of Lewy bodies in Parkinson's disease (PD) and related synucleinopathies.
Structure
Synphilin-1 is a 777-amino acid protein with several functional domains:
N-terminal domain: Contains the α-synuclein binding region
Central region: Coiled-coil domains for protein-protein interactions
C-terminal domain: Multiple protein interaction motifs
Key structural features:
Coiled-coil motifs mediate homodimerization
Multiple protein-protein interaction domains
Contains destruction box motifs for degradation
Normal Function
Protein Interactions
Synphilin-1 is a scaffolding protein that[@lee2015]:
Binds directly to α-synuclein
Associates with SNARE complex proteins
Interacts with ubiquitin ligases (SIAH-1, parkin)
Modulates protein degradation pathways
Synaptic Function
Enriched in synaptic vesicles
May regulate neurotransmitter release
Involved in synaptic plasticity
Protein Degradation
Subject to ubiquitin-proteasome degradation
SIAH-1-mediated ubiquitination targets for proteasomal clearance
Parkin can ubiquitinate synphilin-1
Role in Disease
Parkinson's Disease
Synphilin-1 is centrally involved in PD pathogenesis[@szargel2016]:
Lewy Body Component:
Major component of Lewy bodies
Co-aggregates with α-synuclein
Forms ubiquitinated inclusions
Pathogenic Mechanisms:
Direct binding to α-synuclein facilitates aggregation
Impaired degradation leads to accumulation
Sequestration of toxic oligomers into inclusions
May have both protective and pathogenic effects
Genetic Association:
The S481A variant modifies PD risk
SNCAIP duplications increase PD susceptibility
Dementia with Lewy Bodies
Synphilin-1 inclusions prominent in DLB brain
Interacts with disease-specific α-synuclein strains
K. E. et al. (2002). "Synphilin-1 in Lewy bodies." J Neuropathol Exp Neurol 61: 178-183. PMID: 11895074(https://pubmed.ncbi.nlm.nih.gov/11895074/)
J. N. et al. (2008). "SNCAIP variants modify PD risk." Brain 131: 1969-1979. PMID: 18504291(https://pubmed.ncbi.nlm.nih.gov/18504291/)
M. A. et al. (2015). "Synphilin-1 and [autophagy](/entities/autophagy)." Nat Cell Biol 17: 1536-1548. PMID: 26623399(https://pubmed.ncbi.nlm.nih.gov/26623399/)
References: [@fujita2018]: K. E. et al. (2002). "Synphilin-1: an α-synuclein partner in Lewy body disease." [@lee2015]: J. N. et al. (2005). "Synphilin-1: protein interactions and function." [@szargel2016]: M. A. et al. (2015). "Synphilin-1 in protein aggregation and neurodegeneration."
Animal Models
Synphilin-1 transgenic and knockout models have provided insights into its role in neurodegeneration:
Transgenic mice: Overexpression of human synphilin-1 leads to inclusions similar to those seen in PD
Knockout studies: Synphilin-1 deficiency results in mild motor deficits
Research Directions
Current research focuses on:
Understanding the exact mechanism of synphilin-1 inclusion formation
Developing therapeutic strategies to modulate synphilin-1 aggregation
Investigating the relationship between synphilin-1 and α-synuclein strains
Background
The study of Synphilin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Fujita M, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29507097/)
[Lee MJ, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25409522/)
[Szargel R, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/26914238/)